Mullersman J E, Shields J J, Saha B K
Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.
Hum Genet. 1992 Mar;88(5):589-92. doi: 10.1007/BF00219351.
Two new polymorphisms within the human parathyroid hormone (PTH) gene are described. One corresponds to a C----A transversion that destroys DraII and NlaIV restriction sites. The other is revealed by the enzyme XmnI, and its position has been mapped with respect to the PTH gene. We have also identified a sequence change that results in the TaqI restriction fragment length polymorphism (RFLP) described previously at this locus and have found that this sequence change also results in disruption of a BstBI site. Finally, we describe a polymerase chain reaction (PCR)-based method that permits a rapid evaluation of the DraII and BstBI (TaqI) polymorphisms. The introduction of these two additional RFLPs and this PCR-based assay should considerably extend the power of genetic analyses of the human PTH gene.
本文描述了人类甲状旁腺激素(PTH)基因中的两个新多态性。一个是对应于C到A的颠换,该颠换破坏了DraII和NlaIV限制酶切位点。另一个是由XmnI酶揭示的,其位置已相对于PTH基因进行了定位。我们还鉴定出一个序列变化,该变化导致了先前在此位点描述的TaqI限制片段长度多态性(RFLP),并且发现该序列变化还导致了一个BstBI位点的破坏。最后,我们描述了一种基于聚合酶链反应(PCR)的方法,该方法可快速评估DraII和BstBI(TaqI)多态性。这两个额外的RFLP以及这种基于PCR的检测方法的引入,应能大大扩展人类PTH基因遗传分析的能力。